{"id":"W2981659669","doi":"10.1016/j.thromres.2019.09.033","title":"Rivaroxaban plus aspirin for cardiovascular protection: Rationale for the vascular dose and dual pathway inhibition","year":2019,"lang":"en","type":"review","venue":"Thrombosis Research","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Boehringer Ingelheim; Bayer; Pfizer","keywords":"Rivaroxaban; Aspirin; Medicine; Pharmacology; Thrombin generation; ATHEROSCLEROTIC VASCULAR DISEASE; Coronary artery disease; Thrombin; Vascular disease; Cardiology; Platelet; Internal medicine; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001780502,0.001326276,0.003379584,0.00195139,0.0002990325,0.001753019,0.001723044,0.002551655,0.003985523],"category_scores_gemma":[0.001717328,0.000465308,0.001651673,0.001877264,0.001057543,0.00200477,0.0008425335,0.005892605,0.002065103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008920337,"about_ca_system_score_gemma":0.001355041,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009466341,"about_ca_topic_score_gemma":0.001819972,"domain_scores_codex":[0.9994992,0.0001262778,0.00009485492,0.0001130388,0.000132495,0.00003412886],"domain_scores_gemma":[0.9991002,0.0005892655,0.0001092879,0.00002399162,0.0001438888,0.00003331952],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005664154,0.0001845858,0.0001555331,0.04018267,0.0008127763,0.0002524075,0.00005999664,0.0004984084,0.001575396,0.01896522,0.03640693,0.9003397],"study_design_scores_gemma":[0.0005442925,0.0004392959,0.0008350627,0.01538133,0.001523737,0.0013138,0.00005702698,0.0003383233,0.0005960368,0.007648831,0.9712651,0.00005714239],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000640096,0.9983778,0.000125278,0.0005653538,0.000282128,0.000006622991,0.00002034038,0.000005263988,0.000553145],"genre_scores_gemma":[0.0007123244,0.997024,0.0003761672,0.0009751332,0.0004574066,0.00001418156,0.00002754663,0.000002411849,0.0004108229],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003985523,"threshold_uncertainty_score":0.0133329,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3453645301045887,"score_gpt":0.4302358989388002,"score_spread":0.08487136883421148,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}